Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Control group: One placebo capsule daily (purchased from Poursina Pharmaceutical Company) , which is similar to the main drug in color, smell and taste, is added to their treatment reg
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Suffering from Schizophrenia Do not have any other psychiatric disorder other than schizophrenia, for which a structured interview by a psychiatrist and the patient's test results are used Patients receiving atypical antipsychotic drug Having IQ in the normal range by measuring IQ by Raven test Obtain informed consent from the patient or his / her guardian
Exclusion criteria
Exclusion criteria: Having any physically debilitating disease, whether prominent neurological or organic, including severe kidney and liver disease, for which a clinical examination by a physician and the patient's test results are used. Misuse of drugs or medications in the last six months Receive ECT in the last two weeks Patients who are contraindicated in vitamin B complex consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Loosening of association. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale).;Delirium. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale).;Delusion. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale).;Strange behavior. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale).;Disorganized speech. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale).;Flat or blunted affect. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale)?Calgary Depression Scale for Schizophrenia.;Poverty of speech or poverty of content of speech. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale)?Calgary Depression Scale for Schizophrenia.;Thought blocking. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale)?Calgary Depression Scale for Schizophrenia.;Inappropriate makeup and appearance. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale)?Calgary Depression Scale for Schizophrenia.;Avolition. Timepoint: When entering the study, the end of the fourth, eighth and twelfth week. Method of measurement: PANSS (Positive And Negative Syndrome Scale)?Calgary Depression Scale for Schizophrenia.;Anhedonia. Timepoint: When en | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Aqmasheh
University of social welfare and rehabilitation sciences
Outcome results
None listed